Arvinas, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
ARVN Nasdaq 2830 www.arvinas.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Arvinas, Inc.

Arvinas (ARVN) Upgraded to Strong Buy: Here's What You Should Know - Aug 6th, 2026 10:00 am
Arvinas, Inc. Q2 2026 Earnings Call Summary - Aug 4th, 2026 3:41 pm
Arvinas Q2 Earnings Call Highlights - Aug 4th, 2026 8:04 am
Arvinas, Inc. (ARVN) Beats Q2 Earnings and Revenue Estimates - Aug 4th, 2026 6:50 am
Arvinas Reports Second Quarter 2026 Financial Results and Provides Corporate Update - Aug 4th, 2026 5:00 am
Arvinas to Report Second Quarter 2026 Financial Results on August 4, 2026 - Jul 28th, 2026 5:00 am
Is Kymera Therapeutics Poised for a Breakthrough With KT-621? - Jul 24th, 2026 9:18 am
uniQure (QURE) Soars 78.4%: Is Further Upside Left in the Stock? - Jun 18th, 2026 5:30 am
Rigel Announces Closing of Licensing Agreement for VEPPANU™ (vepdegestrant) - Jun 16th, 2026 2:01 pm
Twist Bioscience (TWST) Surges 9.3%: Is This an Indication of Further Gains? - Jun 12th, 2026 6:25 am
Arvinas Sharpens Pipeline Focus After First PROTAC Approval, Eyes Key Trial Data - Jun 5th, 2026 10:10 am
Arvinas Joins The Michael J. Fox Foundation’s LITE and PPMI Programs to Advance New Therapies Targeting LRRK2 for Parkinson’s Disease - Jun 4th, 2026 6:00 am
Arvinas to Present at Jefferies Global Healthcare Conference - May 29th, 2026 2:01 pm
Arvinas Employees Give Back During Company-wide Impact Day - May 18th, 2026 8:30 am
Bullish: Analysts Just Made A Noticeable Upgrade To Their Arvinas, Inc. (NASDAQ:ARVN) Forecasts - May 16th, 2026 7:40 am
Rigel Pharmaceuticals Inks Breast Cancer Drug Deal With Arvinas, Pfizer - May 15th, 2026 2:31 pm
Earnings Beat: Arvinas, Inc. (NASDAQ:ARVN) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts - May 14th, 2026 6:48 am
Rigel Pharmaceuticals (RIGL) Is Up 20.5% After Global VEPPANU Rights Deal With Pfizer, Arvinas - Has The Bull Case Changed? - May 14th, 2026 12:13 am
These Analysts Increase Their Forecasts On Arvinas After Q1 Results - May 13th, 2026 11:54 am
Aramark To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Wednesday - May 13th, 2026 7:03 am